Novel Modulators of Myc-Mediated Transcription with Potential Use for Cancer Therapy
The compounds in this technology have the potential to influence the activity of Myc proteins such as c-Myc, L-Myc, and N-Myc. They can be applied to modulate (e.g., inhibit) Myc activity in individuals with related medical conditions, treat diseases associated with abnormal Myc activity (e.g., increased activity), manage proliferative diseases, or even prevent Myc-associated diseases. Moreover, they can induce cell apoptosis and serve as valuable research tools for studying Myc activity in biological samples, tissues, or cells.
Researchers
-
myc modulators and uses thereof
United States of America | Granted | 10,017,520
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.